Literature DB >> 3571484

Pseudomonas sp. group Ve-2 bacterial peritonitis in a patient on continuous ambulatory peritoneal dialysis.

I J Amber, L G Reimer.   

Abstract

Pseudomonas sp. group Ve-2 peritonitis occurred in a patient on continuous ambulatory peritoneal dialysis who had recently completed intraperitoneal cephalosporin therapy for culture-negative peritonitis. This is the second reported case of peritonitis in this population of patients due to this unusual organism, which is usually resistant to most cephalosporin antibiotics.

Entities:  

Mesh:

Year:  1987        PMID: 3571484      PMCID: PMC266075          DOI: 10.1128/jcm.25.4.744-745.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Characteristics of yellow-pigmented nonfermentative bacilli (groups VE-1 and VE-2) encountered in clinical bacteriology.

Authors:  G L Gilardi; S Hirschl; M Mandel
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

2.  Group VE-2 (Chromobacterium typhiflavum) bacteremia.

Authors:  F D Pien
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

3.  Group Ve infection: case report of group Ve-2 septicemia and literature review.

Authors:  F D Pien; E Y Chung
Journal:  Diagn Microbiol Infect Dis       Date:  1986-07       Impact factor: 2.803

4.  Characterization of saccharolytic nonfermentative bacteria associated with man.

Authors:  M J Pickett; M M Pedersen
Journal:  Can J Microbiol       Date:  1970-05       Impact factor: 2.419

5.  Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility.

Authors:  M M Pedersen; E Marso; M J Pickett
Journal:  Am J Clin Pathol       Date:  1970-08       Impact factor: 2.493

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Unusual bacterium, group Ve-2, causing peritonitis in a patient on continuous ambulatory peritoneal dialysis.

Authors:  M R Silver; T P Felegie; M I Sorkin
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

8.  Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent.

Authors:  C W Stratton; L B Reller
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

9.  Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.

Authors:  D A Strandberg; J H Jorgensen; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

Review 10.  In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec
View more
  7 in total

1.  A rare cause of peritonitis caused by Flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis (CAPD).

Authors:  Stamatina Papakonstantinou; Evangelia Dounousi; Kyriakos Ioannou; Ioannis Tsouchnikas; Apostolos Kelesidis; Nikolaos Kotzadamis; Dimitrios Tsakiris
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Flavimonas oryzihabitans (formerly CDC group Ve-2) bacteremia in a pediatric patient on assisted ventilation.

Authors:  J Reina; J Odgardd; I Llompart; P Alomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

3.  Flavimonas oryzihabitans as a cause of ocular infection.

Authors:  P N Levett; D A Garrett; T Wickramasuriya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-07       Impact factor: 3.267

4.  Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2): an emerging pathogen in peritonitis related to continuous ambulatory peritoneal dialysis?

Authors:  J W Bendig; P J Mayes; D E Eyers; B Holmes; T T Chin
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

Review 5.  Infections due to Flavimonas oryzihabitans: case report and literature review.

Authors:  J Esteban; M L Valero-Moratalla; R Alcazar; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

6.  Isolation of Flavimonas oryzihabitans (CDC group Ve-2) from catheter-induced bacteremia in an immunocompromised patient.

Authors:  R Mutters; H Köppler; T Krause
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

7.  Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2).

Authors:  J Freney; W Hansen; J Etienne; F Vandenesch; J Fleurette
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.